Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
- Status
- RECRUITING
- Phase
- PHASE2
CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
Couples' QOL in Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Olaparib Maintenance Therapy in Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Exploring Whether Disease-free Intervals Can Guide Endocrine Combined Targeted Therapy for ER+/HER2+ Advanced Breast Cancer (T-sunflower)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Metastatic Breast Cancer-Specific Prognostic Tool
- Status
- COMPLETED
- Phase
- N/A
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Doxil/Caelyx BE Study
- Status
- COMPLETED
- Phase
- PHASE1
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
BRaziLian outcomE for metAStatic breasT Cancer
- Status
- UNKNOWN
- Phase
- N/A
Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Impact of 18F-FES PET on the Therapeutic Treatment of Patients With Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Mecapegfilgrastim for the Prevention of Dalpiciclib -Induced Neutropenia in Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2